Literature DB >> 23027217

Current concepts in the etiology and treatment of keloids.

Michelle C Naylor1, Anthony E Brissett.   

Abstract

Keloids are benign, fibroproliferative growths that occur as a result of dermal injury in ~15% of the population. They are characterized by their extension beyond the confines of the original injury and often present with pain and pruritus. Additionally, these growths may result in cosmetic deformities and contribute to significant emotional distress. It is thought that keloids form as a result of aberrancies in the normal wound-healing process, which is complex and involves an elegant interplay between multiple cell types, cytokines, and proteins. The exact etiology is unknown, but significant research efforts have been made. These efforts have revealed that various cell types in keloids are either hyperresponsive and/or overproductive of various growth factors. Additionally, keloid cell types respond differently to mechanical strain than skin cells in patients who do not form keloids. This lack of understanding of keloid pathophysiology has left the care provider with a lack of a single definitive treatment strategy. Instead, a multitude of therapies exist ranging from surgery to injectables to lasers and any combination thereof. This purpose of this article is to highlight our current knowledge and emerging scientific understanding of keloid pathology and the current management strategies. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2012        PMID: 23027217     DOI: 10.1055/s-0032-1325644

Source DB:  PubMed          Journal:  Facial Plast Surg        ISSN: 0736-6825            Impact factor:   1.446


  8 in total

Review 1.  [Therapy of hypertrophic scars and keloids].

Authors:  R Aschoff
Journal:  Hautarzt       Date:  2014-12       Impact factor: 0.751

2.  LncRNA GNAS-AS1 knockdown inhibits keloid cells growth by mediating the miR-188-5p/RUNX2 axis.

Authors:  Yun Liu; Lei Li; Jia-Yao Wang; Fei Gao; Xia Lin; Shi-Shuai Lin; Zhi-Yang Qiu; Zun-Hong Liang
Journal:  Mol Cell Biochem       Date:  2022-08-29       Impact factor: 3.842

3.  Cross-talk between TGF-β/Smad pathway and Wnt/β-catenin pathway in pathological scar formation.

Authors:  Qiang Sun; Shu Guo; Chen-Chao Wang; Xu Sun; Di Wang; Nan Xu; Shi-Feng Jin; Ke-Zhu Li
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

4.  Calcium Electroporation for Keloids: A First-in-Man Phase I Study.

Authors:  Hanne Falk; Mille Vissing; Gitte Wooler; Julie Gehl
Journal:  Dermatology       Date:  2021-03-31       Impact factor: 5.366

5.  Models of abnormal scarring.

Authors:  Bommie F Seo; Jun Yong Lee; Sung-No Jung
Journal:  Biomed Res Int       Date:  2013-09-03       Impact factor: 3.411

6.  Examination of Epithelial Mesenchymal Transition in Keloid Tissues and Possibility of Keloid Therapy Target.

Authors:  Hiroaki Kuwahara; Mamiko Tosa; Seiko Egawa; Masahiro Murakami; Ghazizadeh Mohammad; Rei Ogawa
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-11-28

7.  Long non-coding RNA CACNA1G-AS1 promotes calcium channel protein expression and positively affects human keloid fibroblast migration.

Authors:  Ye Li; Xuebing Liang; Peng Wang; Xiao Long; Xiaojun Wang; Zhiqiang Meng
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

Review 8.  Small Leucine-Rich Proteoglycans in Skin Wound Healing.

Authors:  Xiaoxiao Pang; Nuo Dong; Zhong Zheng
Journal:  Front Pharmacol       Date:  2020-01-28       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.